TATA健康(01255)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01255 TATA健康

交易中 08-11 10:27:28

2.470

+0.000

0.00%

最高2.470	最低2.470	成交量0.00
今开2.470	昨收2.470	日振幅0.00%
总市值6.00亿	流通市值6.00亿	总股本2.43亿
成交额0.00	换手率0.00%	流通股本2.43亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01255","market":"HK","secType":"STK","nameCN":"TATA健康","latestPrice":2.47,"timestamp":1786411211513,"preClose":2.47,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":242845000,"shares":243000000,"eps":0.054973,"marketStatus":"交易中","change":0,"latestTime":"08-11 10:27:28","open":2.47,"high":2.47,"low":2.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.055,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1786420800000},"marketStatusCode":2,"adr":0,"listingDate":1373472000000,"exchange":"SEHK","adjPreClose":2.47,"openAndCloseTimeList":[[1786411800000,1786420800000],[1786424400000,1786435200000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01255","defaultTab":"news","newsList":[{"id":"1173098803","title":"TATA健康更新7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1173098803","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173098803?lang=zh_cn&edition=full","pubTime":"2026-08-05 14:35","pubTimestamp":1785911735,"startTime":"0","endTime":"0","summary":"TATA健康国际控股有限公司（股票代码：01255）于2026年8月5日公布了截至2026年7月31日的证券变动月报。报告显示，公司本月股本结构稳定，未发生新的发行、回购或注销等活动。\n根据公告，截至7月底，公司法定股本维持500,000,000股，面值每股0.01港元，法定股本总额500万港元。公司已发行股份总数为242,845,000股，库存股份数量为0股，与上月数字一致。本月未新增发行股份及未发生购回、注销或库藏股等变动。\n公告显示，公司确认其于报告期内继续符合香港联合交易所有限公司上市规则有关公众持股量的规定。月报由董事张鸣琪签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148969230","title":"STT与Tata Communications合资公司：在可行情况下协助客户迁移至替代容量","url":"https://stock-news.laohu8.com/highlight/detail?id=1148969230","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148969230?lang=zh_cn&edition=full","pubTime":"2026-06-24 21:50","pubTimestamp":1782309021,"startTime":"0","endTime":"0","summary":"STT与Tata Communications成立的合资公司正致力于在条件允许的情况下，协助客户将其业务迁移至替代的容量资源。此举旨在为客户提供更灵活、更具适应性的解决方案，以满足其不断变化的需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STT","IE00BGHQF748.EUR","LU1894683264.USD","BK4588","01255","BK1601","BK1602","LU1894683348.USD","IE00B64PRP62.GBP","BK1114","LU1883839398.USD","IE00B3QW5Z07.USD","TAATF","IE0034235188.USD","BK4135","LU0061475181.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167334088","title":"TATA健康拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1167334088","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167334088?lang=zh_cn&edition=full","pubTime":"2026-04-27 20:31","pubTimestamp":1777293105,"startTime":"0","endTime":"0","summary":"TATA健康于香港联合交易所上市，董事会近日宣布拟授予董事一般授权，最多可购回不超过公司已发行股本总数10%的股份。根据公告，公司当前已发行股本为242,845,000股，本次回购规模最高可达24,284,500股。本次购回授权尚待股东大会审议，其有效期将持续至下届股东周年大会结束或被股东撤回之日为止。公司亦计划在2026年5月20日召开股东周年大会，并将于5月15日至5月20日期间暂停办理股份过户登记。董事会呼吁股东适时关注后续公告及大会决议事项。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"TATA健康拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175539279","title":"TATA健康2025年中期营收4,211.80万港元，经调整净利润2,059.60万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175539279","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175539279?lang=zh_cn&edition=full","pubTime":"2026-04-24 08:37","pubTimestamp":1776991029,"startTime":"0","endTime":"0","summary":"根据公告披露，TATA健康截至2025年6月30日止六个月营收为4,211.80万港元，同比下降41.8%。同期经调整净利润2,059.60万港元，相较去年同期的亏损状况实现扭亏为盈。毛利率由上年同期的76.6%提升至82.7%。经营现金流在本期净流入474.40万港元，而去年同期为净流出1,410.90万港元。保健、金融服务及线上医疗等板块均因经营策略调整或业务停滞，在报告期内未产生收入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181942406","title":"TATA健康2024年中期营收0.72亿港元，毛利率76.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181942406","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181942406?lang=zh_cn&edition=full","pubTime":"2026-04-24 08:32","pubTimestamp":1776990750,"startTime":"0","endTime":"0","summary":"TATA健康公告显示，截至2024年6月30日止六个月，公司实现营收约0.72亿港元，同比上一年同期的1.04亿港元下滑30.6%。同期毛利率为76.6%，较上一年同期的81.9%有所下降。经营活动所产生的现金流由上一年同期的流入474.4万港元转为本期流出1,404.2万港元。鞋类业务是主要收入来源，报告期实现收入0.72亿港元，同比减少28.2%。受市场环境与消费情绪等因素影响，其余业务板块规模较小，保健业务与线上医疗服务在报告期内均无收入进账，金融服务收入也为零。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154265011","title":"TATA健康(01255)2025年度盈利扭转 业务聚焦鞋类零售 毛利率升至80.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1154265011","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154265011?lang=zh_cn&edition=full","pubTime":"2026-04-23 07:47","pubTimestamp":1776901661,"startTime":"0","endTime":"0","summary":"TATA健康国际控股有限公司于2025财政年度实现收入约9,979.90万元，同比下降23.2%。尽管全年收入下滑，毛利约8,026.40万元，毛利率由上年度的69.5%提升至80.4%。公司拥有人应占溢利约1,335.00万元，而上年度则为亏损约6,833.80万元，每股盈利由亏损0.28港元扭转至盈利0.05港元，显示公司整体盈利能力明显改善。报告期内，公司主营鞋类业务，占收入比重的100%。展望后续，公司表示将持续通过丰富产品策略与强化管控，以提升品牌竞争力和应对零售市场的环境变化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TATA健康(01255)2025年度盈利扭转 业务聚焦鞋类零售 毛利率升至80.4%","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164624221","title":"TATA健康（01255）2024年收入降至1.24亿港元 亏损翻倍且呈负资产状态","url":"https://stock-news.laohu8.com/highlight/detail?id=1164624221","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164624221?lang=zh_cn&edition=full","pubTime":"2026-04-22 08:59","pubTimestamp":1776819555,"startTime":"0","endTime":"0","summary":"TATA健康国际控股有限公司公布截至2024年12月31日止年度业绩。报告期内，公司收入为1.24亿港元，同比下降40.0%，主要由鞋类业务收入萎缩所致。同期毛利约为8,494.80万元，毛利率由上一年度的72.6%降至68.3%。由于销售下滑及减值开支增加，2024年除税前亏损达6,803.10万元，本公司拥有人应占亏损为6,833.80万元，同比增加逾一倍。每股基本亏损为0.28港元，上年同期则为每股盈利0.13港元。从业务板块来看，鞋类业务录得收入1.25亿港元，保健和金融等其他板块暂未形成实际收入。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"TATA健康（01255）2024年收入降至1.24亿港元 亏损翻倍且呈负资产状态","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142670318","title":"TATA健康2023年收入同比提升逾四成 毛利率下滑且净资产转负","url":"https://stock-news.laohu8.com/highlight/detail?id=1142670318","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142670318?lang=zh_cn&edition=full","pubTime":"2026-04-22 08:49","pubTimestamp":1776818970,"startTime":"0","endTime":"0","summary":"TATA健康于截至2023年12月31日止年度实现约2.08亿港元收入，较上一年度的约1.45亿港元增长逾四成，主要受鞋类业务销售增长带动。期间毛利约1.51亿港元，同比上升约32%，但毛利率从78.8%回落至72.6%。管理层指出，香港零售市场在疫情后逐步回暖，但原材料及薪资成本上扬、店铺租金及市场推广开支维持高位，整体盈利能力受到一定程度挤压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TATA健康2023年收入同比提升逾四成 毛利率下滑且净资产转负","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627453905","title":"TATA健康(01255)：朱俊豪辞任非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2627453905","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2627453905?lang=zh_cn&edition=full","pubTime":"2026-04-13 20:42","pubTimestamp":1776084157,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告， 朱俊豪先生因其决定将更多时间投入其他工作安排，已提呈辞任非执行董事，自2026年4月9日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427943.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01255","BK1601","BK1602","BK1114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182696180","title":"TATA健康3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1182696180","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182696180?lang=zh_cn&edition=full","pubTime":"2026-04-09 19:12","pubTimestamp":1775733121,"startTime":"0","endTime":"0","summary":"2026年4月9日，TATA健康发布2026年3月股份变动月报表。公告显示，截至报告期末，公司注册股本维持在500,000,000股，面值每股港币0.01元，注册股本总额5,000,000港币与上月保持一致。已发行股本方面，截至2026年3月31日，公司已发行股份总数仍为242,845,000股，期间无新增发行、购回、注销或库藏股活动。本次月报表由公司董事张鸣琪签署，TATA健康确认继续遵守香港联交所《上市规则》及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624153502","title":"TATA健康(01255)发布年度业绩 股东应占溢利1335万港元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2624153502","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2624153502?lang=zh_cn&edition=full","pubTime":"2026-04-01 00:00","pubTimestamp":1774972830,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布截至2025年12月31日止年度业绩，该集团取得收入9979.9万港元，同比减少23.04%;公司拥有人应占年内溢利1335万港元，去年同期亏损6833.8万港元;每股基本盈利0.05港元。公告称，于本年度，鞋类业务的收入占集团总收入的100%。集团鞋类业务于本年度的收入约为9980万港元，同比减少23.1%。集团鞋类业务收益减少，主要由于经济持续不明朗导致消费意欲疲弱，为本年度香港零售业带来严峻环境。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1114","BK1601","01255","BK1602"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171655687","title":"【交易快讯】TATA健康（01255）补充公告：完成出售目标公司 2,000万港元融资担保全部解除","url":"https://stock-news.laohu8.com/highlight/detail?id=1171655687","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171655687?lang=zh_cn&edition=full","pubTime":"2026-03-17 19:15","pubTimestamp":1773746150,"startTime":"0","endTime":"0","summary":"香港，2026年3月17日—TATA健康国际控股有限公司发布补充公告，就3月13日已完成的出售目标公司事项提供进一步信息。\\n\\n根据此前协议，买方作为贷款人曾向目标公司的直接全资附属公司KTS HK提供2,000万港元信贷融资，并以三项资产作担保：\\n1. KTS HK持有物业的法定押记；\\n2. 集团间接全资附属公司Grand Asian Limited存货的浮动押记；\\n3. KTS HK应收款项的浮动押记。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149526704","title":"TATA健康(01255)1港元转让Kong Tai Sundry Goods (BVI) 全部股权 预计录得约410万港元收益","url":"https://stock-news.laohu8.com/highlight/detail?id=1149526704","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149526704?lang=zh_cn&edition=full","pubTime":"2026-03-13 21:32","pubTimestamp":1773408761,"startTime":"0","endTime":"0","summary":"3月13日，TATA健康国际控股有限公司公告称，全资附属S. Culture Holdings  Limited已与香港公司Wealthy Steps Company Limited签订协议，以1港元转让Kong Tai Sundry Goods  Company Limited全部已发行股本。交易即日完成后，目标公司及其两家附属公司不再并入TATA健康的合并报表。截至2025年12月31日，目标集团总资产约2,230万港元，净负债约410万港元。TATA健康表示，出售协议条款属正常商业条件，符合公司及股东整体利益。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619190064","title":"TATA健康(01255)附属拟1港元出售Kong Tai Sundry Goods (BVI) Company Limited全部股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2619190064","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2619190064?lang=zh_cn&edition=full","pubTime":"2026-03-13 21:31","pubTimestamp":1773408663,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康 发布公告,于2026年3月13日，卖方S.Culture Holdings  Limited与买方WealthySteps Company Limited订立出售协议，据此，卖方有条件同意出售，而买方有条件同意收购销售股份，代价为1.00港元。完成于出售协议日的同日发生，而Kong Tai Sundry Goods  Company Limited不再为公司的附属公司，目标集团的财务业绩亦不再并入集团综合财务报表。目标集团处于亏损、高债务及净负债状况。董事会认为，出售事项可减轻集团对目标集团的财务负担。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01255","BK1601","BK1114","BK1602"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133680054","title":"TATA健康国际（01255）2026年2月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1133680054","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133680054?lang=zh_cn&edition=full","pubTime":"2026-03-02 18:45","pubTimestamp":1772448336,"startTime":"0","endTime":"0","summary":"2026年3月2日，TATA健康国际控股有限公司公布了截至2026年2月28日的证券变动月报表。报告显示，于本月公司股本结构维持稳定，未有新增发行或回购注销活动。公司注册股本维持在5,000,000港元，本月无增减变动。截至2月底，公司已发行股份及库存股份数目分别维持在242,845,000股及0股，总已发行股份数同样未作调整。公告由公司董事张鸣琪签署。公司表示将持续关注股本结构变化，并在有需要时及时披露。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511351549","title":"TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2511351549","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511351549?lang=zh_cn&edition=full","pubTime":"2025-02-13 16:53","pubTimestamp":1739436788,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。此外，继续停牌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1601","BK1602","01255","BK1114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491904643","title":"TATA健康：未就任何可能出售抵押股份订立任何确实交易文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2491904643","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491904643?lang=zh_cn&edition=full","pubTime":"2024-12-13 12:35","pubTimestamp":1734064500,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　TATA健康（01255）发布公告，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-13/doc-inczhtrv2918937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1601","BK1114","BK1602","01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491390634","title":"TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2491390634","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491390634?lang=zh_cn&edition=full","pubTime":"2024-12-13 12:27","pubTimestamp":1734064032,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224427.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1601","01255","BK1602","BK1114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483828383","title":"TATA健康(01255)：接管人仍正在识别潜在买方，且尚未达致销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2483828383","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483828383?lang=zh_cn&edition=full","pubTime":"2024-11-14 17:01","pubTimestamp":1731574919,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告，经本公司作出查询后，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1210905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1602","BK1114","BK1601","01255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2475321375","title":"TATA健康：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2475321375","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2475321375?lang=zh_cn&edition=full","pubTime":"2024-10-15 08:35","pubTimestamp":1728952539,"startTime":"0","endTime":"0","summary":"TATA健康（01255）发布公告，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。\n　　此外，继续停牌。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-15/doc-incsqtkc1425815.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-15/doc-incsqtkc1425815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1602","BK1114","01255","BK1601"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.s-culture.com","stockEarnings":[{"period":"1week","weight":0.1762},{"period":"1month","weight":-0.1179},{"period":"3month","weight":0.3},{"period":"6month","weight":0.6467},{"period":"1year","weight":7.2333},{"period":"ytd","weight":0.9}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.0729},{"period":"3month","weight":-0.0156},{"period":"6month","weight":-0.0487},{"period":"1year","weight":0.0434},{"period":"ytd","weight":0.012}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"TATA健康国际控股有限公司(原名：港大零售国际控股有限公司)是一家主要从事销售鞋类产品的投资控股公司。该公司通过四个分部运营业务。鞋类业务分部从事销售品牌名为Clarks、Josef Seibel、The Flexx和Petite Jolie的鞋类产品。金融服务业务分部提供证券的顾问服务，投资管理服务和企业融资的顾问服务。保健业务分部从事销售品牌名为AXS和Bio Lands及其他品牌的保健品以及Aptamil奶粉。线上医疗服务业务分部提供医疗服务，如医疗的顾问及咨询。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.046955},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.02637},{"month":3,"riseRate":0.545455,"avgChangeRate":0.224197},{"month":4,"riseRate":0.636364,"avgChangeRate":0.058824},{"month":5,"riseRate":0.454545,"avgChangeRate":0.033977},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.015804},{"month":7,"riseRate":0.181818,"avgChangeRate":0.066603},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.034687},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.077045},{"month":10,"riseRate":0.454545,"avgChangeRate":0.035169},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.031106},{"month":12,"riseRate":0.416667,"avgChangeRate":0.294855}],"exchange":"SEHK","name":"TATA健康","nameEN":"TATA HEALTH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TATA健康(01255)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TATA健康(01255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TATA健康,01255,TATA健康股票,TATA健康股票老虎,TATA健康股票老虎国际,TATA健康行情,TATA健康股票行情,TATA健康股价,TATA健康股市,TATA健康股票价格,TATA健康股票交易,TATA健康股票购买,TATA健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TATA健康(01255)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TATA健康(01255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}